Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Cordex Pharma, Inc. | cdxp_10q.htm |
| EX-32.1 - CERTIFICATION - Cordex Pharma, Inc. | cdxp_ex321.htm |
| EX-31.2 - CERTIFICATION - Cordex Pharma, Inc. | cdxp_ex312.htm |
| EX-31.1 - CERTIFICATION - Cordex Pharma, Inc. | cdxp_ex311.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Cordex Pharma, Inc. (the “Company”) on Form 10-Q, for the quarterly period ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wayne Lorgus, the Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| By: | /s/ Wayne Lorgus |
|
| Wayne Lorgus Chief Financial Officer |
November 16, 2009